The European Federation for Medicinal Chemistry (EFMC) is an independent association representing medicinal chemistry societies in Europe. Its objective is to advance the science of medicinal chemistry by promoting cooperation and networking, by providing training and mentoring, by rewarding scientific excellence, and by facilitating communication and influencing stakeholders.

Meetings  May 2018 Next

EFMC Sponsorship rules can be found in the by-laws, point E.

  • Macrocycles 2018 - 3rd RSC BMCS Medicinal Chemistry Symposium on Macrocycles

    October 8-9, 2018   Stevenage, United Kingdom

    The objective of this symposium is to promote scientific interaction between scientists with a shared interest in the field of Macrocycles. This area is responsible for a growing number of therapeutic approaches and development candidates, all of which go ‘beyond the rule-of–five’. As a researcher in this field, come along to hear about the latest advances and also to share in some of the secrets of discovering therapeutic agents which go beyond Lipinski’s rules.

    Confirmed Speakers

    • Frank Fang, Eisai, United States
    • William McCoull, AstraZeneca, United Kingdom
    • Daniel Obrecht, Polyphor, Switzerland
    • Vicky Steadman, Selcia, United Kingdom

    Contact person: Mrs Maggi Churchouse
    Email: maggi@maggichurchouseevents.co.uk
    Tel: +44 (0)1359 221004


M T W T F S S
30 01 02 03 04 05 06
07 08 09 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31 01 02 03
All events   |  Future events

Job portal

27/04/2018
MsC student or PhD internship, KU Leuven: Cellular and Molecular Medicine, Leuven, Belgium
read more


20/04/2017
Medicinal / Synthetic Organic Chemists, Concept Life Sciences: Drug Discovery, Sandwich, Kent, United Kingdom
read more


Job portal page

Follow us on Facebook

Follow us on Twitter

Follow us on LinkedIn

Follow us on Instagram

ChemBridgeBoehringer IngelheimNovartisProf Dr W. Th. Nauta FoundationPfizerServierRoche
 Prous Institute for Biomedical ResearchUCBJanssen R&DBayerMerck